Lipoprotein(a): The Science Behind the Risk Factor
Lipoprotein(a): The Science Behind the Risk Factor is organized by American Heart Association (AHA).
Release Date: 04/09/2021
Expiration Date: 04/08/2024
Target Audience:
• Physicians - Cardiologists, interventional cardiologists, preventative cardiologists, LDL specialists, general cardiologists
• Nurses
• Nurse Practitioners
• Other – Physician Assistants
Description:
What role does Lp(a) play in dyslipidemia and adverse events, including atherogenesis? Join Dr. Marlys L. Koschinsky PhD, FAHA, FNLA, FCAHS, OOnt and Dr. Florian Kronenberg, MD, as they explore the key points of Lp(a) structure and how this is related to its pathological properties and determination of plasma Lp(a) levels. What is the science behind the risk factor? Register today to learn the latest thinking on the contribution of variation in the LPA gene encoding apo(a) to plasma Lp(a) levels.
Learning Objectives :
At the completion of this course, the learner will be able to:
• Describe the key features of Lp(a) structure.
• Compare Lp(a) structure with that of other lipoprotein classes.
• Distinguish the contribution of Lp(a) biosynthesis versus Lp(a) catabolism in determining plasma Lp(a) levels.
• Recognize the importance of oxidized phospholipid modification of apo(a) on the pathogenicity of Lp(a).
• Define the epidemiology of Lp(a) concentrations in health and cardiovascular disease.
• Recognize the genetic regulation of Lp(a) concentrations.
• Identify the advantage of a Mendelian randomization study.
• Describe the discussion about thresholds of Lp(a).